225 related articles for article (PubMed ID: 6696534)
21. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
Barr JW; Lakin RC; Rösch J
Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
[TBL] [Abstract][Full Text] [Related]
22. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
23. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
[TBL] [Abstract][Full Text] [Related]
24. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
25. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
[TBL] [Abstract][Full Text] [Related]
26. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
27. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
28. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
[TBL] [Abstract][Full Text] [Related]
29. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
[TBL] [Abstract][Full Text] [Related]
30. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
Herz R; Rössle M; Bonzel T; Keller E; Gerok W
Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
[TBL] [Abstract][Full Text] [Related]
31. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
Willems B; Villeneuve JP; Huet PM
Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
[TBL] [Abstract][Full Text] [Related]
32. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
[TBL] [Abstract][Full Text] [Related]
33. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
[TBL] [Abstract][Full Text] [Related]
34. Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
J Clin Gastroenterol; 1991 Aug; 13(4):424-31. PubMed ID: 1918848
[TBL] [Abstract][Full Text] [Related]
35. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
Eriksson LS; Law DH; Sato Y; Wahren J
Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
[TBL] [Abstract][Full Text] [Related]
36. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results.
Rodríguez-Laiz JM; Bañares R; Echenagusia A; Casado M; Camuñez F; Pérez-Roldán F; de Diego A; Cos E; Clemente G
Dig Dis Sci; 1995 Oct; 40(10):2121-7. PubMed ID: 7587778
[TBL] [Abstract][Full Text] [Related]
37. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: a study of vasopressin and nitroglycerin.
Iwao T; Toyonaga A; Sumino M; Takagi K; Oho K; Ohkubo K; Inoue R; Tanikawa K
J Gastroenterol Hepatol; 1992; 7(2):148-53. PubMed ID: 1571496
[TBL] [Abstract][Full Text] [Related]
38. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
39. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis.
Ota K; Shijo H; Kokawa H; Kubara K; Kim T; Akiyoshi N; Yokoyama M; Okumura M
J Gastroenterol Hepatol; 1995; 10(2):198-204. PubMed ID: 7787167
[TBL] [Abstract][Full Text] [Related]
40. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
Millette B; Huet PM; Lavoie P; Viallet A
Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]